Bolt Biotherapeutics, Inc. Quarterly Current Ratio in % from Q3 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Bolt Biotherapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2021 to Q3 2024.
  • Bolt Biotherapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 457 %, a 38.2% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 457 -283 -38.2% Sep 30, 2024
Q2 2024 546 -206 -27.4% Jun 30, 2024
Q1 2024 621 -183 -22.7% Mar 31, 2024
Q4 2023 675 -175 -20.6% Dec 31, 2023
Q3 2023 740 -149 -16.7% Sep 30, 2023
Q2 2023 751 -200 -21% Jun 30, 2023
Q1 2023 804 -220 -21.5% Mar 31, 2023
Q4 2022 851 -370 -30.3% Dec 31, 2022
Q3 2022 889 -270 -23.3% Sep 30, 2022
Q2 2022 951 Jun 30, 2022
Q1 2022 1.02K Mar 31, 2022
Q4 2021 1.22K Dec 31, 2021
Q3 2021 1.16K Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.